Electronic Trial Master File (eTMF) Systems Market Size 2031

Report Description

Electronic Trial Master File (eTMF) Systems Market Outlook 2031

The global electronic trial master file systems market size was USD 0.79 Billion in 2022 and is likely to reach USD 2.43 Billion by 2031, expanding at a CAGR of 14.2% during 2023–2031. The market is driven by the increasing use of electronic documentation.

Growing use of eTMF systems in clinical research activities is anticipated to boost the market during the assessment period. The enhanced data security features in eTMF systems help protect sensitive clinical trial data from unauthorized access and breaches. Furthermore, the rise in clinical trial activities, including the development of new drugs and chemical devices, is likely to fuel the requirement for eTMF systems in the coming years.

• In January 2021, Parexel, a prominent CRO, launched its eTMF solution to assist clients in managing the documentation of clinical trials in a secure, centralized, and yielding manner. The introduction of this solution marks a significant milestone for Parexel, as it is part of the company's tech-based services suite for clinical trials. This solution is envisioned to meet the rising need for eTMF solutions in various biopharmaceutical companies.

Get Free Sample Report

The expansion of clinical trials across geographical boundaries requires effective collaboration and data management. The availability of mobile-friendly eTMF solutions helps in obtaining real-time updates and remote access, thereby improving the flexibility and collaboration among companies conducting the trials. These factors are projected to propel the market in the coming years.

The COVID-19 pandemic fueled the market owing to the shortage of sufficient research for the development of vaccines during the treatment of patients. It was a major health crisis and required intensive trials to determine the most effective treatments.

Consequently, the surge in the demand for clinical trials and treatment plans that could be effective. The high requirement for clinical research organizations (CROs) to ensure proper documentation of these trials created lucrative opportunities for the market.

Artificial Intelligence (AI) Impact on Electronic Trial Master File (eTMF) Systems Market

The use of artificial intelligence is likely to provide substantial propulsion to the electronic trial master file systems market. AI helps streamline document management by automating various activities such as data extraction, classification, and organization. This reduces the need for manual labor and diminishes the margin for human error. Additionally, it ensures compliance and risk management through intelligent data analytics.

Electronic Trial Master File (eTMF) Systems Market Dynamics

Get Free Sample Report

Major Drivers

Increasing adoption of electronic records is expected to drive the market during the projection period. The use of electronic records in clinical trials helps in fostering a digital approach to document management.

These records allow real-time data collection and seamless integration with eTMF systems, thereby reducing the manual paperwork and streamlining the trial process. This enhanced efficiency and the compliance benefits is likely to fuel the market during the projection period.

• In 2020, Bioclinica, a leading clinical trial services provider, completed the acquisition of an eTMF solution provider called SMO Clinical Trial Billing Solutions. This acquisition was a strategic move by Bioclinica to expand its contributions to eTMF and solutions for the financial management of clinical trials. As a result of this acquisition, Bioclinica is better equipped to offer a comprehensive suite of clinical trial services to its clients.

Existing Restraints

Lack of trained professionals for operating eTMF systems is likely to hamper the market during the forecast period. eTMF systems require specialized expertise to set up and operate these devices.

As a result, the effective utilization of these systems for clinical trials depends on professionals who can interpret and manage the digital documentation while ensuring compliance. As a result, the absence of skilled professionals can lead to a decline in the adoption of eTMF systems, thereby causing a market slowdown.

Emerging Opportunities

­Stringent regulatory compliance is anticipated to provide substantial growth opportunities for the market. These regulations require pharmaceutical companies to maintain comprehensive and accurate documentation throughout the drug development process.

eTMF systems offer a streamlined approach for managing these documents electronically, reducing the margin for errors and improving data integrity. This is expected to create lucrative prospects in the market in the coming years.

Scope of Electronic Trial Master File (eTMF) Systems Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Electronic Trial Master File (eTMF) Systems Market Segment Insights

Component Segment Analysis

Based on component, the electronic trial master file systems market is divided into services and software. The services segment is projected to hold the major share of the market during the projection period, as eTMF systems facilitate improved efficient management of trial-related documents, allowing for easy retrieval, organization, and tracking of necessary data.

This reduces the risk of document loss and ensures regulatory compliance. Transitioning to eTMFs reduces the need for physical storage and manual record-keeping, thereby significantly saving time and cost, and streamlining the trial process. This is anticipated to boost the services segment of the market during the projection period.

Get Free Sample Report

Deployment Mode Segment Analysis

On the basis of deployment mode, the global market is segregated into on-premise and cloud/web-based. The cloud/web-based segment is projected to register a high CAGR during the forecast period due to the easy accessibility and collaboration through cloud portals.

Cloud/web-based systems allow full authorization to the trial documents and data from anywhere with an internet connection. The flexibility of these systems facilitates the management of large and complex clinical trials with a wide range of document and data storage requirements. This is likely to propel the segment during the assessment period.

End-user Segment Analysis

On the basis of end-user, the electronic trial master file systems market is segmented into contract research organizations, pharmaceutical and biotechnology companies, and others. The pharmaceutical and biotechnology companies segment is anticipated to expand at a robust pace during the forecast period as eTMF systems facilitate collaboration among geographically dispersed teams, making it easy for researchers and sponsors to work together in an effective and efficient manner.

This helps in accelerating the drug development process. Additionally, rapid expansion of the pharmaceutical industry is leading to high adoption of eTMF systems by them to ensure seamless workflow. This hastens the trial process, which is projected to fuel the segment in the coming years.

• As per a survey published in October 2023, the pharmaceutical industry has grown at a significant pace in the past two decades. The revenue generated by this industry in 2022 was approximately USD 1.48 trillion.

Get Free Sample Report

Regional Outlook

In terms of region, the global electronic trial master file systems market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period due to the use of advanced healthcare analytics and the rise in clinical trial outsourcing.

The expansion of the biopharmaceutical industry in this region has increased the demand for clinical trials in this region. Furthermore, the surge in awareness of data security and regulatory compliance is anticipated to propel the market during the forecast period.

The market in Europe is projected to significantly expand owing to the high demand for cloud-based solutions. The need for compliance with the latest regulations and increasing collaboration among pharmaceutical and biopharmaceutical companies, which is expected to create significant market propulsion in the coming years.

Get Free Sample Report